These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 29868482)

  • 1. Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy.
    Saleh T; Tyutynuk-Massey L; Cudjoe EK; Idowu MO; Landry JW; Gewirtz DA
    Front Oncol; 2018; 8():164. PubMed ID: 29868482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis?
    Ohtani N
    Inflamm Regen; 2022 Apr; 42(1):11. PubMed ID: 35365245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies.
    Chakrabarty A; Chakraborty S; Bhattacharya R; Chowdhury G
    Front Oncol; 2021; 11():674354. PubMed ID: 34249714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma.
    Homann L; Rentschler M; Brenner E; Böhm K; Röcken M; Wieder T
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Jekyll and Hyde of Cellular Senescence in Cancer.
    Demirci D; Dayanc B; Mazi FA; Senturk S
    Cells; 2021 Jan; 10(2):. PubMed ID: 33494247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-Induced Senescence: Novel Approaches for Markers Identification.
    Pacifico F; Magni F; Leonardi A; Crescenzi E
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells.
    Chaturvedi P; George V; Shrestha N; Wang M; Dee MJ; Zhu X; Liu B; Egan J; D'Eramo F; Spanoudis C; Gallo V; Echeverri C; You L; Kong L; Fang B; Jeng EK; Rhode PR; Wong HC
    Mol Ther; 2022 Mar; 30(3):1171-1187. PubMed ID: 35051615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?
    Liu Y; Lomeli I; Kron SJ
    Cells; 2024 Jul; 13(15):. PubMed ID: 39120312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senescent cells in cancer therapy: why and how to remove them.
    Zhang JW; Zhang D; Yu BP
    Cancer Lett; 2021 Nov; 520():68-79. PubMed ID: 34237406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular senescence and the tumour microenvironment.
    Takasugi M; Yoshida Y; Ohtani N
    Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB.
    Camorani S; Cerchia L; Fedele M; Erba E; D'Incalci M; Crescenzi E
    Oncotarget; 2018 Apr; 9(28):19929-19944. PubMed ID: 29731994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-Induced Senescence: An "Old" Friend Becomes the Enemy.
    Saleh T; Bloukh S; Carpenter VJ; Alwohoush E; Bakeer J; Darwish S; Azab B; Gewirtz DA
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Paradoxical Role of Cellular Senescence in Cancer.
    Yang J; Liu M; Hong D; Zeng M; Zhang X
    Front Cell Dev Biol; 2021; 9():722205. PubMed ID: 34458273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SASP factor IL-6 sustains cell-autonomous senescent cells via a cGAS-STING-NFκB intracrine senescent noncanonical pathway.
    Herbstein F; Sapochnik M; Attorresi A; Pollak C; Senin S; Gonilski-Pacin D; Ciancio Del Giudice N; Fiz M; Elguero B; Fuertes M; Müller L; Theodoropoulou M; Pontel LB; Arzt E
    Aging Cell; 2024 Jul; ():e14258. PubMed ID: 39012326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence.
    Liao C; Xiao Y; Liu L
    Cancer Manag Res; 2020; 12():13553-13566. PubMed ID: 33408525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLL1 is essential for the senescence-associated secretory phenotype.
    Capell BC; Drake AM; Zhu J; Shah PP; Dou Z; Dorsey J; Simola DF; Donahue G; Sammons M; Rai TS; Natale C; Ridky TW; Adams PD; Berger SL
    Genes Dev; 2016 Feb; 30(3):321-36. PubMed ID: 26833731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
    Malaquin N; Tu V; Rodier F
    Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
    Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
    Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senescence and the tumor-immune landscape: Implications for cancer immunotherapy.
    Chibaya L; Snyder J; Ruscetti M
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):827-845. PubMed ID: 35143990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.